Montelukast Sodium Tablet, Chewable
Product Images NDC 71205-189

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 71205-189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Montelukast Sodium Tablets And Chewable Tablets 1)

The text represents a chart showing the change in height (in centimeters) over the course of 56 weeks for a group of 360 individuals who were given one of three treatments - Montelukast Sodium at 5mg (n=120), Beclomethasone at 336mg (n=119), or a Placebo (n=121). The chart is labeled "Shomesas" and shows data points at weeks 0, 16, 24, 32, 40, 48, and 56.*

FDA Label Image

Chemical Structure (Montelukast Sodium Tablets And Chewable Tablets 2)

FDA Label Image

Figure 2 (Montelukast Sodium Tablets And Chewable Tablets 3)

FDA Label Image

71205-189-30 (Montelukast Sodium Tablets And Chewable Tablets 4)

This is a description of a medication called Montelukast Sodium with a strength of 4mg in chewable tablet form. The tablets are round and light pink, and each tablet has "KU" on one side and "204" on the other. The medication is for pediatric patients between the ages of 2-5. The medication should be stored at 25°C (77°F) and kept out of the reach of children. The tablets come in a bottle of 30 and are distributed by Lannett Company, Inc. The packaging information is included along with the lot numbers and expiry date. The GTIN is 00371205189303.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.